MedTrace Logo

Carbon Nanoparticles vs Indocyanine Green

NCT04759820 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 298

Last updated 2021-02-18

No results posted yet for this study

Summary

Both nano carbon and ICG as lymph node tracers in colorectal cancer have their own value, this study was to contrast two tracers in colorectal cancer surgeries, so as to find out the best lymphnode tracer in colorectal cancer, in order to further improve postoperative lymph node inspection, precise postoperative adjuvant therapy and improve the patients' long-term survival.

Conditions

  • Number of Lymph Node Retrieved

Interventions

DRUG

injecting Carbon Nanoparticles Suspension

injecting Carbon Nanoparticles Suspension for lymph node detection

DRUG

Injecting indocyanine green

Injecting indocyanine green for lymph node detection

Sponsors & Collaborators

  • LI XIN-XIANG

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-06-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04759820 on ClinicalTrials.gov